Arcadia Biosciences
Arcadia Biosciences
RKDA
NASDAQ
3.41
USD
1.79%
About
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola). Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (Non-GMO) project verified and only contains 60 calories per serving.
It offers Zola in different varieties, such as Original, Slightly Sweetened; Original with Pulp, Slightly Sweetened; Espresso, Slightly Sweetened; Pineapple; Lime; and others. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 7.8K |
| Three Month Average Volume | 179.2K |
| High Low | |
| Fifty-Two Week High | 4.79 USD |
| Fifty-Two Week Low | 1.8512 USD |
| Fifty-Two Week High Date | 01 Sep 2023 |
| Fifty-Two Week Low Date | 15 Apr 2024 |
| Price and Volume | |
| Current Price | 3.1074 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 9.75% |
| Thirteen Week Relative Price Change | -5.12% |
| Twenty-Six Week Relative Price Change | 2.77% |
| Fifty-Two Week Relative Price Change | -29.15% |
| Year-to-Date Relative Price Change | -16.16% |
| Price Change | |
| One Day Price Change | 6.24% |
| Thirteen Week Price Change | 1.55% |
| Twenty-Six Week Price Change | 13.00% |
| Five Day Price Change | 9.82% |
| Fifty-Two Week Price Change | -11.22% |
| Year-to-Date Price Change | -0.72% |
| Month-to-Date Price Change | 12.18% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 9.99035 USD |
| Book Value Per Share (Most Recent Quarter) | 8.58795 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 9.96001 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 8.55933 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -7.04592 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 4.30906 USD |
| Revenue Per Share (Trailing Twelve Months) | 3.71611 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -10.63921 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -3.091 USD |
| Normalized (Last Fiscal Year) | -10.36753 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -10.63921 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -3.091 USD |
| Including Extraordinary Items (Last Fiscal Year) | -11.30295 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -4.98317 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 9.05753 USD |
| Cash Per Share (Most Recent Quarter) | 5.94934 USD |
| Cash Flow Per Share (Last Fiscal Year) | -10.41126 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -2.9156 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -9.3358 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -374 |
| Cash Flow Revenue (Trailing Twelve Months) | -251 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -82.94% |
| Pretax Margin (Last Fiscal Year) | -246.85% |
| Pretax Margin (5 Year) | -261.47% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 46.42% |
| Gross Margin (Trailing Twelve Months) | 48.14% |
| Gross Margin (5 Year) | 53.54% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -261.50% |
| Operating Margin (Trailing Twelve Months) | -122.81% |
| Operating Margin (5 Year) | -331.15% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -247.00% |
| Net Profit Margin (Trailing Twelve Months) | -83.08% |
| Net Profit Margin (5 Year) | -261.13% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -37.81% |
| Tangible Book Value (5 Year) | -0.02% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 0.69% |
| Revenue Growth (3 Year) | 29.49% |
| Revenue Change (Trailing Twelve Months) | 7.82% |
| Revenue Per Share Growth | -22.64% |
| Revenue Growth (5 Year) | -12.78% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -54.27% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -41.65% |
| EPS Change (Trailing Twelve Months) | 74.16% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 0 |
| Price to Tangible Book (Most Recent Quarter) | 0 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -8,108,000 |
| Net Debt (Last Fiscal Year) | -11,642,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 |
| Price to Sales (Trailing Twelve Months) | 1 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 43 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 4 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 0 |
| Price to Book (Most Recent Quarter) | 0 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 4 |
| Quick Ratio (Most Recent Quarter) | 4 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 4 |
| Current Ratio (Most Recent Quarter) | 5 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -15,299,000 |
| Free Cash Flow (Trailing Twelve Months) | -12,712,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -54.15% |
| Return on Assets (Trailing Twelve Months) | -19.04% |
| Return on Assets (5 Year) | -42.96% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -77.70% |
| Return on Equity (Trailing Twelve Months) | -28.43% |
| Return on Equity (5 Year) | -71.60% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -64.06% |
| Return on Investment (Trailing Twelve Months) | -22.33% |
| Return on Investment (5 Year) | -50.46% |